A leading Chinese COVID-19 vaccine developed by Sinovac Biotech was just 50.38 per cent effective in late-stage trials in Brazil, significantly lower than earlier results showed, according to a statement published by the government of Sao Paulo Tuesday.
Click to copy the Short Url to this post:
More on Upstract
